Chemoradiotherapy treatment trang 1 tải miễn phí từ TAILIEUCHUNG

"Chemoradiotherapy treatment" trang 1 - tải miễn phí từ Tailieuchung

Long-term results of early adjuvant concurrent chemoradiotherapy for highrisk, early stage uterine cervical cancer patients after radical hysterectomy

Long-term results of early adjuvant concurrent chemoradiotherapy for highrisk, early stage uterine cervical cancer patients after radical hysterectomy

7 62 1

The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer

The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer

9 49 1

Evaluation of results of conformal concurrent chemoradiotherapy at the dose of 50.5 Gy in the treatment of non surgical esophageal cancer at 103 Military Hospital

Evaluation of results of conformal concurrent chemoradiotherapy at the dose of 50.5 Gy in the treatment of non surgical esophageal cancer at 103 Military Hospital

8 105 0

CRITICS-II: A multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

CRITICS-II: A multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

12 48 1

Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer

Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer

10 32 1

A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: Based on SUVmean and NLR

A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: Based on SUVmean and NLR

11 55 1

Preliminary results of treatment extranodal NK/T-Cell lymphoma, nasal type stage I-II at K hospital

Preliminary results of treatment extranodal NK/T-Cell lymphoma, nasal type stage I-II at K hospital

5 42 1

Báo cáo y học: "Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: Experience from a single institution"

6 31 0

báo cáo khoa học:

báo cáo khoa học: "Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma"

7 29 0

Báo cáo khoa học:

Báo cáo khoa học: "Concurrent chemoradiotherapy in adjuvant treatment of breast cancer"

13 73 0

Intensity modulated radiation therapy in the definitive treatment for cervical and upper thoracic esophageal cancer: Clinical outcome and acute toxicity

Intensity modulated radiation therapy in the definitive treatment for cervical and upper thoracic esophageal cancer: Clinical outcome and acute toxicity

8 81 0

Clinical and paraclinical characteristics of locally advanced distal gastric adenocarcinoma patients underwent the treatment of postoperative adjuvant chemoradiotherapy at Hue Central Hospital

Clinical and paraclinical characteristics of locally advanced distal gastric adenocarcinoma patients underwent the treatment of postoperative adjuvant chemoradiotherapy at Hue Central Hospital

6 70 0

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: The IpiGlio trial protocol

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: The IpiGlio trial protocol

5 78 0

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

11 46 1

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis

6 72 1

Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate

Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate

7 47 1

Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: A retrospective study

Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: A retrospective study

9 34 1

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer

9 28 1

Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

10 63 1

Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

9 10 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.